http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2100817-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e9445e5e3626f36e932c6451a928250
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-37
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
filingDate 1993-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_992c0a554fdf0d18feba55e0bf45d354
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f7ef610344c5cce5bc7953efdbc8e8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9702c1c4d79463caeb710094d26bb512
publicationDate 1994-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2100817-A1
titleOfInvention Heteroacetic acid derivatives
abstract Disclosed are compounds of formula (see formula I) wherein R is hydrogen, hydroxy, esterified hydroxy or etherified hydroxy; R1 is hydrogen, halogen, trifluoromethyl or lower alkyl; R2 is hydrogen, halogen, trifluoromethyl or lower alkyl; R3 is halogen, trifluoromethyl, lower alkyl, aryl, aryl-lower alkyl, cycloalkyl or cycloalkyl-lower alkyl; or R3 is the radical (see formula II) wherein R8 is hydrogen, lower alkyl, aryl, cycloalkyl, aryl-lower alkyl or cycloalkyl-lower alkyl; R9 is hydroxy or acyloxy; R10 represents hydrogen or lower alkyl; or R9 and R10 together represent oxo; R4 is hydrogen, halogen, trifluoromethyl or lower alkyl; X is -NR7; W is O or S; R5 and R6 together represent oxo; R7 represents hydrogen or lower alkyl; Z represents carboxyl, carboxyl derivatized as a pharmaceutically acceptable ester or as a pharmaceutically acceptable amide; and pharmaceutically acceptable salts thereof; which are useful as hypocholesteremic agents.
priorityDate 1992-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044

Total number of triples: 33.